Significantly, these phenotypes were observed both in the GBA1 mutant homozygous lines vs. WT controls as well as the PD lines carrying heterozygous GBA1 mutations, with clear differences from the mutation corrected isogenic controls, demonstrating that GBA1 heterozygotes, while usually devoid of clinical symptoms, do show cellular phenotypes. Here, GBA1 is linked to Parkinson disease.